Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $835.5750 (-1.18%) ($835.5750 - $835.5750) on Tue. Oct. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.17% (three month average) | RSI | 52 | Latest Price | $835.5750(-1.18%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | REGN advances 0.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(65%) IBB(59%) DIA(57%) SDY(53%) SPY(53%) | Factors Impacting REGN price | REGN will decline at least -0.585% in a week (0% probabilities). VXX(-45%) VIXM(-39%) TBT(-24%) USO(-17%) GLD(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.585% (StdDev 1.17%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $838.52(-0.35%) | 10 Day Moving Average | $834.52(0.13%) | 20 Day Moving Average | $830.62(0.6%) | To recent high | -1.2% | To recent low | 16.2% | Market Cap | $88.595b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |